Published in Law and Health Weekly, February 12th, 2005
Under the arrangement, Biophan will also acquire the exclusive license to fifteen issued and pending patents covering imaging of devices such as stents and other vascular implants, significantly expanding the company's intellectual property portfolio. The parties are expected to execute the definitive agreement and complete due diligence on or before January 31, 2005.
When completed, the acquisition of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly